Search Results
May 27, 2026, 08:01 ET Is $9.50 Per Share a Fair Buyout Price for Global Business Travel Group (GBTG) Shareholders?
https://kaskelalaw.com/case/global-business-travel-group/On May 4, 2026, Amex GBT disclosed its agreement to become a private entity, valuing each share at $9.50 in cash. Once this transaction is finalized, public investors in Amex GBT will have their investment positions converted to cash, and the company's
More news about: Kaskela Law LLC
May 04, 2026, 14:05 ET Shareholder Alert: Ademi LLP investigates whether Global Business Travel Group, Inc. is obtaining a Fair Price for Public Shareholders
you.Amex GBT stockholders will receive $9.50 per share in an all-cash transaction valued at $6.3 billion. Amex GBT insiders will receive substantial benefits as part of change of control arrangements.The transaction agreement unreasonably limits competing transactions for Amex GBT by imposing
More news about: Ademi LLP
Apr 30, 2026, 14:09 ET /C O R R E C T I O N -- Hippocratic AI/
of its healthcare-specialized AI. The release marks a turning point in AI for healthcare. In comparative evaluations against frontier models (Claude, GBT, Gemini), Polaris 5.0 leads on the dimensions that determine whether voice AI can be deployed in real care settings: clinical accuracy, HIPAA and regulatory
More news about: Hippocratic AI
Apr 24, 2026, 06:00 ET Guerbet annonce une étape majeure dans l'indication « embolisation vasculaire » pour Lipiodol® Ultra Fluid (Esters éthyliques d'acides gras iodés de l'huile d'œillette)
VILLEPINTE, France, 24 avril 2026 /PRNewswire/ -- GUERBET (FR0000032526 – GBT) Guerbet, leader mondial de l'imagerie médicale, annonce l'obtention d'un résultat positif d'une procédure de worksharing, impliquant
More news about: Guerbet
Apr 24, 2026, 05:00 ET Guerbet announces an important milestone achievement in the "Vascular Embolization" indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)
VILLEPINTE, France, April 24, 2026 /PRNewswire/ -- GUERBET (FR0000032526 GBT): Guerbet, a global leader in medical imaging, announces a positive outcome from a worksharing procedure, involving several EU member states, for
More news about: Guerbet
Apr 24, 2026, 05:00 ET Guerbet verkündet einen wichtigen Meilenstein bei der Indikation „Vaskuläre Embolisation" für Lipiodol® Ultra Fluid (jodiertes Ethylester der Fettsäuren von Mohnsamenöl)
VILLEPINTE, Frankreich, 24. April 2026 /PRNewswire/ -- GUERBET (FR0000032526 GBT): Guerbet, ein weltweit führendes Unternehmen im Bereich der medizinischen Bildgebung, gibt ein positives Ergebnis eines Worksharing-Verfahrens
More news about: Guerbet
Apr 24, 2026, 05:00 ET Guerbet anuncia un importante logro en la indicación de "embolia vascular" para Lipiodol® Ultra Fluid
VILLEPINTE, Francia, 24 de abril de 2026 /PRNewswire/ -- GUERBET (FR0000032526 GBT): Guerbet, líder mundial en diagnóstico por imagen, anuncia un resultado positivo de un procedimiento de colaboración, en el que participaron varios
More news about: Guerbet
Apr 13, 2026, 05:00 ET Business Travel Market Expected to Reach USD 2,095.4 billion by 2031, at a CAGR of 9.5%: Allied Market Research
globally significant business travel market.Competitive LandscapeKey players include American Express Global Business Travel (Amex GBT), BCD Travel, CWT Solutions Group, Flight Centre Travel Group, Corporate Travel Management (CTM), Booking Holdings, Expedia Group, Travel Leaders Group,
More news about: Allied Market Research
Feb 20, 2026, 11:21 ET New indication in pediatric patients, including term neonates for Guerbet's half-dose GBCA, Elucirem™ (Gadopiclenol) Injection
we continuously innovate and dedicate 9% of our revenue to Research & Development across four centers in France and the United States. Guerbet (GBT) is listed on Euronext Paris, Compartment B, and achieved €841 million in revenue in 2024. For more information, please visit
More news about: Guerbet
Jan 28, 2026, 03:15 ET Neue Indikation bei Kindern ab Geburt für Guerbets halbe Dosis GBCA, Elucirem™ (Gadopiclenol), von der Europäischen Kommission zugelassen
VILLEPINTE, Frankreich, 28. Januar 2026 /PRNewswire/ -- Guerbet (FR0000032526 GBT), ein weltweit tätiger Spezialist für Kontrastmittel und Lösungen für die medizinische Bildgebung, freut sich, die Zulassung einer neuen Indikation für
More news about: Guerbet
Jan 27, 2026, 12:00 ET New indication in children from birth for Guerbet's half-dose GBCA, Elucirem™ (Gadopiclenol) approved by European Commission
VILLEPINTE, France, Jan. 27, 2026 /PRNewswire/ -- Guerbet (FR0000032526 GBT), a global specialist in contrast media and solutions for medical imaging, is delighted to announce the approval by European Commission of a new indication
More news about: Guerbet
Jan 27, 2026, 12:00 ET Nouvelle indication dès la naissance pour l'agent de contraste demi-dose de Guerbet, Elucirem™ (Gadopiclenol), approuvée par la Commission européenne
VILLEPINTE, France, 27 janvier 2026 /PRNewswire/ -- Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, a le plaisir d'annoncer que la Commission européenne a approuvé
More news about: Guerbet
Jan 27, 2026, 12:00 ET Nueva indicación en niños desde el nacimiento para Elucirem™ (gadopiclenol) aprobada por la Comisión Europea
VILLEPINTE, Francia, 27 de enero de 2026 /PRNewswire/ -- Guerbet (FR0000032526 GBT), un especialista global en medios de contraste y soluciones para imágenes médicas, se complace en anunciar la aprobación por parte de la Comisión Europea
More news about: Guerbet
Sep 30, 2025, 11:53 ET Autonomous Defense Networks Grow as Approximately $28B Investment Wave Transforms Military Communications
"Background Projects" where discussions with third parties are underway. The venture also incorporates GBT Tokenize Corp. with a preliminary independent patent portfolio valuation of $300 million, and GBT Technologies Inc. with additional equity stakes. VisionWave has
More news about: USA News Group
Sep 26, 2025, 10:30 ET Global Threat Surge Leads to $2.7T Defense Spending Boom and Institutional Rush
where discussions with third parties are underway. The venture also incorporates GBT Tokenize Corp. with a preliminary independent patent portfolio valuation of $300 million, and GBT Technologies Inc. with additional equity stakes. VisionWave has
More news about: Equity Insider
Sep 26, 2025, 10:02 ET Defense Tech Surge Attracts $28B Institutional Rush as AI Security Threats Multiply
where discussions with third parties are underway. The venture also incorporates GBT Tokenize Corp. with a preliminary independent patent portfolio valuation of $300 million, and GBT Technologies Inc. with additional equity stakes. VisionWave has
More news about: USA News Group